Research News

UK Study Potentially Links Low Blood Amylin Level to Reduced Progression of Alzheimer’s Disease

Jan 21, 2021, 8:41 AM

Florin Despa says that a major scientific goal is to understand whether the same factors that are involved in age-related metabolic disorders such as type-2 diabetes may also play a role in the development and progression of cognitive decline and dementia.

UK’s Sanders-Brown Center on Aging Director Elected as AAAS Fellow

Nov 24, 2020, 1:04 PM

Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers. Van Eldik is one of only six women from UK that have been awarded this honor and she is the first since 1966.

'Behind the Blue': Dr. Peter Nelson Discusses UK’s Leading Efforts on Alzheimer’s and Dementia Research

Nov 20, 2020, 8:27 AM

Dr. Peter Nelson, of the University of Kentucky’s Sanders-Brown Center on Aging, has spent the last 15 years in the Commonwealth helping to lead the fight against Alzheimer’s and dementia inducing brain disease.

Multi-Million Dollar Multidisciplinary Grant Supports Advancement of Epilepsy Research

Oct 27, 2020, 8:45 AM

A $2.9 million grant from the NIH is supporting a multidisciplinary team of UK researchers in continuing their work to find therapeutic strategies to resolve neurovascular inflammation and repair blood-brain barrier dysfunction in epilepsy.

Screen%20Shot%202020-10-23%20at%201.21.35%20PM.png

10th Annual Sanders-Brown Markesbery Symposium on Aging and Dementia Taking Place Virtually

Oct 27, 2020, 8:23 AM

In the sessions for both the scientific and community audience, attendees will have the opportunity to hear clinicians and researchers from UK and other institutions share current findings, trends, and latest updates on dementia and aging disorders.

Butterfield Recognized as a Leading Alzheimer’s Expert

Oct 9, 2020, 8:29 AM

Butterfield is among the top 0.007% of scholars worldwide based on authorship of Alzheimer’s-related publications indexed in the PubMed database for the past 10 years. He ranks tenth out of nearly 150,000 scholars worldwide and sixth in the U.S.

New Study Looks at Encoding the Odor of Cigarette Smoke

Sep 30, 2020, 8:13 AM

In addition to opening the door to developing blockers of odors, McClintock says this work will help researchers understand why formulating fragrances and flavors with specific properties is so difficult. “Ergo, the oft-used phrase 'the art of perfumery.' Eventually, we will turn this art into science.”

Sanders-Brown Research Discovers New Pathway in TDP-43 Related Dementias

Sep 23, 2020, 9:46 AM

Selenica says their study is the first to provide a novel pathway and identify potential therapeutic targets for TDP-43 proteinopathies – especially in Alzheimer’s disease and the newly characterized form of dementia known as LATE.

Sanders-Brown Study Leads to Potential New Treatment Approach for Alzheimer’s Disease

Aug 25, 2020, 8:18 AM

Through the group's work, they found that the therapeutic targeting of TREM2 using a TREM2-activating antibody leads to the activation of microglia, recruitment of microglia to amyloid plaques, reduced amyloid deposition, and ultimately improved cognition.

UK’s Sanders-Brown, Penn Researchers Provide Insights into Newly Characterized Form of Dementia

Aug 25, 2020, 8:12 AM

“We used to think that aging-related memory and thinking decline meant one thing: a disease called Alzheimer’s disease. Now we know that the disease we were calling Alzheimer’s disease is actually many different conditions, often in combination."

Filter News

Unit

News type

Topic

Series